Nx GEN SEQUENCING FAMILIAL HEMIPLEGIC MIGRAINE Test
Test Cost: AED 4680.0
Symptoms and Diagnosis
Familial hemiplegic migraine (FHM) is a rare genetic disorder that causes severe migraines along with temporary paralysis or weakness on one side of the body. It is an inherited condition, and genetic testing can be used to identify specific gene mutations associated with FHM.
Test Components
- ATP1A2
- CACNA1A
- PRRT2
- SCN1A
Price: AED 4680.0
Sample Condition
Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Report Delivery
Sample Daily by 9 am; Report 40 Working days
Method
NGS, Sanger sequencing
Test Type
Genetic Disorders-Migraine
Doctor
Neurologist
Test Department
MOLECULAR DIAGNOSTICS
Pre Test Information
Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Test Details
Familial hemiplegic migraine (FHM) is a rare genetic disorder that causes severe migraines along with temporary paralysis or weakness on one side of the body. It is an inherited condition, and genetic testing can be used to identify specific gene mutations associated with FHM.
Next-generation sequencing (NGS) is a high-throughput DNA sequencing technology that allows for the simultaneous sequencing of multiple genes or even entire genomes. In the case of FHM, NGS can be used to analyze a panel of genes known to be associated with the condition.
The FHM test using NGS involves collecting a DNA sample, usually through a blood sample or saliva sample. The DNA is then extracted and purified in the laboratory. Next, the specific genes associated with FHM are amplified using polymerase chain reaction (PCR) or other techniques. The amplified DNA fragments are then sequenced using NGS technology.
The sequencing data obtained from NGS is analyzed using specialized software to identify any genetic variations or mutations in the FHM-associated genes. These variations can help determine if a person has a genetic predisposition to FHM.
The results of the NGS test for FHM can provide valuable information for diagnosis, genetic counseling, and treatment planning. It can help confirm a clinical diagnosis of FHM, identify the specific gene mutation responsible for the condition, and assess the risk of passing the condition on to future generations.
It is important to note that genetic testing for FHM using NGS may not be available in all healthcare settings and may require consultation with a genetic counselor or specialist. Additionally, while genetic testing can provide valuable information, it is not a standalone diagnostic tool, and clinical evaluation by a healthcare professional is still necessary for an accurate diagnosis of FHM.
Test Name | Nx GEN SEQUENCING FAMILIAL HEMIPLEGIC MIGRAINE Test |
---|---|
Components | ATP1A2, CACNA1A, PRRT2, SCN1A |
Price | 4680.0 AED |
Sample Condition | Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory. |
Report Delivery | Sample Daily by 9 am; Report 40 Working days |
Method | NGS, Sanger sequencing |
Test type | Genetic Disorders-Migraine |
Doctor | Neurologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory. |
Test Details |
Familial hemiplegic migraine (FHM) is a rare genetic disorder that causes severe migraines along with temporary paralysis or weakness on one side of the body. It is an inherited condition, and genetic testing can be used to identify specific gene mutations associated with FHM. Next-generation sequencing (NGS) is a high-throughput DNA sequencing technology that allows for the simultaneous sequencing of multiple genes or even entire genomes. In the case of FHM, NGS can be used to analyze a panel of genes known to be associated with the condition. The FHM test using NGS involves collecting a DNA sample, usually through a blood sample or saliva sample. The DNA is then extracted and purified in the laboratory. Next, the specific genes associated with FHM are amplified using polymerase chain reaction (PCR) or other techniques. The amplified DNA fragments are then sequenced using NGS technology. The sequencing data obtained from NGS is analyzed using specialized software to identify any genetic variations or mutations in the FHM-associated genes. These variations can help determine if a person has a genetic predisposition to FHM. The results of the NGS test for FHM can provide valuable information for diagnosis, genetic counseling, and treatment planning. It can help confirm a clinical diagnosis of FHM, identify the specific gene mutation responsible for the condition, and assess the risk of passing the condition on to future generations. It is important to note that genetic testing for FHM using NGS may not be available in all healthcare settings and may require consultation with a genetic counselor or specialist. Additionally, while genetic testing can provide valuable information, it is not a standalone diagnostic tool, and clinical evaluation by a healthcare professional is still necessary for an accurate diagnosis of FHM. |